University Office (Division)

Search Results

Now showing 1 - 2 of 2

KEMTUB012-NI2, a novel potent tubulysin analog that selectively targets hypoxic cancer cells and is potentiated by cytochrome p450 reductase downregulation
(2017-05-23) Lazzari, Paolo; Spiga, Marco; Sani, Monica; Zanda, Matteo; Fleming, Ian N; University of Aberdeen.Medical Sciences; University of Aberdeen.Medical Sciences - Cardiovascular Group; University of Aberdeen.Medical Education; University of Aberdeen.Aberdeen Biomedical Imaging Centre
Changes in [18F]Fluoro-2-deoxy-D-glucose incorporation induced by doxorubicin and anti-HER antibodies by breast cancer cells modulated by co-treatment with metformin and its effects on intracellular signalling
(2015-09) Cooper, Alasdair C; Fleming, Ian N; Phyu, Su M; Smith, Timothy A D; University of Aberdeen.Applied Medicine; University of Aberdeen.Aberdeen Biomedical Imaging Centre; University of Aberdeen.Medical Sciences